S&P downgrades Emergent BioSolutions outlook on competition
UKPulse Money Desk
S&P has downgraded its outlook on Emergent BioSolutions, citing competitive pressures. The rating action was reported on 18 August 2026.
- S&P downgraded Emergent BioSolutions' outlook.
- The downgrade was attributed to competition.
- The report was published on 18 August 2026.
S&P has downgraded its outlook on Emergent BioSolutions, according to a report published on 18 August 2026. The rating agency cited competition as the reason for the change.
The move reflects heightened competitive pressures facing the company, though no further details were provided in the initial report.